The Mason Bioengineering Alliance organizes and sponsors several events each year related to Bioengineering Education, Research, and Commercialization. The events are open to the public.
Commercialization of University Inventions
The event held on February 21, 2020 was sponsored by Mason Bioengineering Alliance and the Office of Technology Transfer.
Here are the meeting agenda and presentations (PDF) by our sponsors:
- “Nondilutive Funding Landscape” by Vizma Carver, Founder and CEO, Carver Global Health Group
- “Ceres Nanosciences: Licensing University IP and Building a Company” by Ross M. Dunlap, CEO, Ceres Nanosciences
- “CSA Medical: From License to Company Sale” by Richard Hughen, CEO, Linshom & Principal: Life Science Planning
- “Overview of Technology Transfer and Commercialization at Mason” by Hina Mehta, Director, Office of Technology Transfer
- “SPGlobal: a Current Example of a Successful SIBR Pitch” by Eric Vollmecke, Executive VP, SPGlobal
- “Funding Mechanisms from Center for Innovative Technology” by Nancy Vorona, VP Research Investment, Center for Innovative Technology
- “Neuroparticle Corporation: Image-guided therapy with Magnetic Particles” by Elaine Wang, Founder and CEO, Neuroparticl